Observational studyPloS one2025

Protocol for an open labelled observational study in children & adolescents with severe asthma with an eosinophilic phenotype treated with mepolizumab (CASAM).

Atul Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.